Olin (NYSE:OLN - Get Free Report) had its price target decreased by analysts at Citigroup from $26.00 to $25.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a "buy" rating on the specialty chemicals company's stock. Citigroup's price objective would indicate a potential upside of 12.46% from the company's previous close.
A number of other research firms have also recently commented on OLN. UBS Group increased their target price on Olin from $21.00 to $22.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. JPMorgan Chase & Co. reduced their target price on Olin from $28.00 to $20.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Morgan Stanley reduced their target price on Olin from $28.00 to $20.00 and set an "underweight" rating on the stock in a research note on Monday, May 12th. The Goldman Sachs Group reduced their target price on Olin from $33.00 to $25.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Finally, Royal Bank Of Canada cut their price target on shares of Olin from $25.00 to $23.00 and set a "sector perform" rating for the company in a research report on Thursday, July 3rd. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $27.33.
Read Our Latest Report on Olin
Olin Price Performance
Shares of Olin stock traded up $1.16 during trading on Tuesday, hitting $22.23. The stock had a trading volume of 2,790,096 shares, compared to its average volume of 1,702,300. The firm has a market cap of $2.56 billion, a price-to-earnings ratio of 43.59 and a beta of 1.52. Olin has a 12 month low of $17.66 and a 12 month high of $50.75. The business's 50-day moving average is $20.65 and its 200 day moving average is $24.79. The company has a current ratio of 1.56, a quick ratio of 0.96 and a debt-to-equity ratio of 1.48.
Olin (NYSE:OLN - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The specialty chemicals company reported $0.04 earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.14. The firm had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.58 billion. Olin had a net margin of 0.94% and a return on equity of 3.13%. The business's quarterly revenue was up 1.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.40 earnings per share. As a group, sell-side analysts anticipate that Olin will post 1.38 earnings per share for the current year.
Institutional Trading of Olin
Several institutional investors and hedge funds have recently bought and sold shares of OLN. Fuller & Thaler Asset Management Inc. lifted its holdings in Olin by 40.5% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 6,384,744 shares of the specialty chemicals company's stock worth $154,766,000 after buying an additional 1,840,900 shares during the period. Thrivent Financial for Lutherans increased its stake in shares of Olin by 5,746.2% during the fourth quarter. Thrivent Financial for Lutherans now owns 1,613,796 shares of the specialty chemicals company's stock valued at $54,546,000 after purchasing an additional 1,586,192 shares in the last quarter. Norges Bank bought a new position in shares of Olin during the fourth quarter valued at approximately $47,887,000. Hotchkis & Wiley Capital Management LLC increased its stake in shares of Olin by 11.5% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 12,191,163 shares of the specialty chemicals company's stock valued at $295,514,000 after purchasing an additional 1,259,795 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Olin by 14.3% during the first quarter. Dimensional Fund Advisors LP now owns 4,546,352 shares of the specialty chemicals company's stock valued at $110,204,000 after purchasing an additional 569,483 shares in the last quarter. 88.67% of the stock is currently owned by hedge funds and other institutional investors.
About Olin
(
Get Free Report)
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.
Further Reading

Before you consider Olin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olin wasn't on the list.
While Olin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.